EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER

KILIÇKAP S.

NOBEL MEDICUS, cilt.14, sa.3, ss.5-8, 2018 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 3
  • Basım Tarihi: 2018
  • Dergi Adı: NOBEL MEDICUS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.5-8
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Mutation of epidermal growth factor receptor (EGFR) is one of the targeted mutations in treatment of non-small cell lung cancer (NSCLC). Mutation of EGFR occurs in 15-40% of all patients with NSCLC. In this review, efficacy of different EGFR inhibitors used in NSCLC treatment is evaluated.